AAAAAA

   
Results: 1-11 |
Results: 11
COMPLIANCE IN DEPRESSED-PATIENTS TREATED WITH FLUOXETINE OR AMITRIPTYLINE
Authors: DEMYTTENAERE K VANGANSE E GREGOIRE J GAENS E MESTERS P
Citation: K. Demyttenaere et al., COMPLIANCE IN DEPRESSED-PATIENTS TREATED WITH FLUOXETINE OR AMITRIPTYLINE, International clinical psychopharmacology, 13(1), 1998, pp. 11-17
COST-EFFECTIVENESS OF PRAVASTATIN IN SECONDARY PREVENTION OF CORONARYHEART-DISEASE - COMPARISON BETWEEN BELGIUM AND THE UNITED-STATES OF APROJECTED RISK MODEL
Authors: MULS E VANGANSE E CLOSON MC
Citation: E. Muls et al., COST-EFFECTIVENESS OF PRAVASTATIN IN SECONDARY PREVENTION OF CORONARYHEART-DISEASE - COMPARISON BETWEEN BELGIUM AND THE UNITED-STATES OF APROJECTED RISK MODEL, Atherosclerosis (Amsterdam), 137, 1998, pp. 111-116
USE OF ORAL XANTHINES IN THE ELDERLY AND EXTENT OF SILENT RISKS - INFORMATION FROM A DRUG DISPENSING DATABASE
Authors: VANGANSE E VINCKEN W LEUFKENS H ERNST P
Citation: E. Vanganse et al., USE OF ORAL XANTHINES IN THE ELDERLY AND EXTENT OF SILENT RISKS - INFORMATION FROM A DRUG DISPENSING DATABASE, Pharmacoepidemiology and drug safety, 6(2), 1997, pp. 135-136
EFFECTS OF ANTIHISTAMINES IN ADULT ASTHMA - A METAANALYSIS OF CLINICAL-TRIALS
Authors: VANGANSE E KAUFMAN L DERDE MP YERNAULT JC DELAUNOIS L VINCKEN W
Citation: E. Vanganse et al., EFFECTS OF ANTIHISTAMINES IN ADULT ASTHMA - A METAANALYSIS OF CLINICAL-TRIALS, The European respiratory journal, 10(10), 1997, pp. 2216-2224
ASSESSING ASTHMA MANAGEMENT FROM INTERVIEWS OF PATIENTS AND FAMILY PHYSICIANS (VOL 34, PG 203, 1997)
Authors: VANGANSE E LEUFKENS HGM VINCKEN W HUBLOUE I BARTSCH P BOUCKAERT A ERNST P
Citation: E. Vanganse et al., ASSESSING ASTHMA MANAGEMENT FROM INTERVIEWS OF PATIENTS AND FAMILY PHYSICIANS (VOL 34, PG 203, 1997), The Journal of asthma, 34(6), 1997, pp. 567-567
ASSESSING ASTHMA MANAGEMENT FROM INTERVIEWS OF PATIENTS AND FAMILY PHYSICIANS
Authors: VANGANSE E LEUFKENS HGM VINCKEN W HUBLOUE I BARTSCH P BOUCKAERT A ERNST P
Citation: E. Vanganse et al., ASSESSING ASTHMA MANAGEMENT FROM INTERVIEWS OF PATIENTS AND FAMILY PHYSICIANS, The Journal of asthma, 34(3), 1997, pp. 203-209
ACTUAL USE OF INHALED CORTICOSTEROIDS AND RISK OF HOSPITALIZATION - ACASE-CONTROL STUDY
Authors: VANGANSE E HUBLOUE I VINCKEN W LEUFKENS HGM GREGOIRE J ERNST P
Citation: E. Vanganse et al., ACTUAL USE OF INHALED CORTICOSTEROIDS AND RISK OF HOSPITALIZATION - ACASE-CONTROL STUDY, European Journal of Clinical Pharmacology, 51(6), 1997, pp. 449-454
ECONOMIC-ANALYSIS OF LIPID-LOWERING COST IN BELGIUM
Authors: MULS E VANGANSE E CLOSON MC
Citation: E. Muls et al., ECONOMIC-ANALYSIS OF LIPID-LOWERING COST IN BELGIUM, Atherosclerosis, 130, 1997, pp. 153-153
ANTIALLERGIC AND ANTITUSSIVE MEDICATIONS - EXTENT OF USE AND RELATIONSHIP TO ASTHMA EXACERBATIONS
Authors: VANGANSE E VANDERLINDEN P LEUFKENS HGM VINCKEN W ERNST P
Citation: E. Vanganse et al., ANTIALLERGIC AND ANTITUSSIVE MEDICATIONS - EXTENT OF USE AND RELATIONSHIP TO ASTHMA EXACERBATIONS, Therapie, 51(4), 1996, pp. 373-377
ASTHMA MEDICATIONS AND DISEASE EXACERBATIONS - AN EPIDEMIOLOGIC-STUDYAS A METHOD FOR ASTHMA SURVEILLANCE
Authors: VANGANSE E VANDERLINDEN PD LEUFKENS HGM HERINGS RMC VINCKEN W ERNST P
Citation: E. Vanganse et al., ASTHMA MEDICATIONS AND DISEASE EXACERBATIONS - AN EPIDEMIOLOGIC-STUDYAS A METHOD FOR ASTHMA SURVEILLANCE, The European respiratory journal, 8(11), 1995, pp. 1856-1860
USE OF DATABASES IN PHARMACOVIGILANCE - 2 EXAMPLES
Authors: VANGANSE E
Citation: E. Vanganse, USE OF DATABASES IN PHARMACOVIGILANCE - 2 EXAMPLES, Therapie, 50(5), 1995, pp. 409-412
Risultati: 1-11 |